CYTEK BIOSCIENCES INC. - COMMON STOCK
6.7700
25-November-24 09:32:50
15 minutes delayed
Stocks
+0.2200
+3.36%
Today's range
6.5100 - 6.7700
ISIN
N/A
Source
NASDAQ
-
Cytek Biosciences Reports Second Quarter 2023 Financial Results
08 Aug 2023 15:05:01 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
20 Jul 2023 16:26:35 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
31 May 2023 15:05:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Announces $50 Million Stock Repurchase Program
19 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
16 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports First Quarter 2023 Financial Results
09 May 2023 15:05:03 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
20 Apr 2023 15:05:00 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Introduces New 20-Color AML Panel
07 Mar 2023 16:00:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
28 Feb 2023 15:05:01 By Nasdaq GlobeNewswire
-
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
28 Feb 2023 08:21:38 By Nasdaq GlobeNewswire
-
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
13 Feb 2023 15:07:03 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
07 Feb 2023 15:05:00 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
07 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
06 Feb 2023 15:05:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
21 Nov 2022 15:05:00 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Introduces Cytek Cloud
15 Nov 2022 09:00:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Third Quarter 2022 Financial Results
09 Nov 2022 15:05:01 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Names Chris Williams Chief Operating Officer
31 Oct 2022 15:30:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
26 Oct 2022 15:05:00 By Nasdaq GlobeNewswire
-
Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare Conference
30 Aug 2022 15:05:00 By Nasdaq GlobeNewswire